We are thrilled to announce that the Dr. Ralph & Marian Falk Medical Research Trust has awarded $500,000 to the Solve ME/CFS Initiative to further our epigenetic research. READ MORE…
Research Digest – December 2014: 10 Important Advances in ME/CFS
While progress is still far too slow, there have been many recent interesting and important discoveries in ME/CFS. In this year-end blog post, Dr. Vernon and Dr. Komaroff summarize what they regard as the most important recent advances in our field. READ MORE…
Being “Patient-Centric”
Patients are central to a solution for ME/CFS. We have designed our SolveCFS BioBank™ to collect and manage data so that the individual is the central organizing principle. LEARN MORE…
Deciphering Post-Exertional Malaise
On September 18, 2014, Dane B. Cook, Ph.D., Associate Professor of Kinesiology at the University of Wisconsin, Madison and a Solve ME/CFS Initiative 2011 funded investigator, presented our most popular webinar of the year on the system biology approach his team is taking to provide a clear picture as to what causes post-exertional malaise. In this guest post for our blog, Dr. Cook reviews the material presented and tackles the many questions we received from webinar participants.
The Importance of a Representative Patient Population for Research
Being able to offer researchers access to ME/CFS patients with demographic and clinical characteristics that represent the full range of people affected with ME/CFS removes a significant hurdle all researchers face. With the SolveCFS BioBank™ we can make ME/CFS research more appealing and accessible. But how do we ensure our SolveCFS BioBank™ is representative of the entire patient population? READ MORE….
Research Digest – September 2014: Cortisol in ME/CFS
Cortisol is an essential hormone for immune function and many studies have shown that cortisol is low in ME/CFS patients – known as hypocortisolism. In this month’s research digest, we review three studies that look at the effect of cortisol on function and post-exertional malaise in ME/CFS…
Research Digest – August 2014: More Results from the SolveCFS BioBank
More results from the work being done through the SolveCFS BioBank: We are pleased to report the publication of the initial BioBank study on XMRV and the publication of the first study of epigenetics in ME/CFS. Both used the clinical information and samples from the SolveCFS BioBank that were collected in 2010. READ MORE…
SolveCFS BioBank: Calling YOU to Participate in Gathering a Breadth & Depth of ME/CFS Data, Part 4 of 4
The SolveCFS BioBank allows us to seek out and attract the brightest investigators, allowing multiple research projects on participant samples where results are combined. ME/CFS is complex, like a jigsaw puzzle. When you participate in the BioBank, different research studies are brought together. READ MORE in part 4 of 4 of this series…
SolveCFS BioBank: Breaking Down Barriers Through Biomarker Discovery, Part 3 of 4
In the short time our SolveCFS BioBank has been in operation, it has proven to be an attractive resource drawing some of the best and brightest investigators into ME/CFS research. In this 3rd part of our SolveCFS BioBank series we feature two investigators who are working on biomarker discovery.
SolveCFS BioBank: Breaking Down Barriers to ME/CFS Research, part 2 of 4
The SolveCFS BioBank is an important resource to attract the brightest investigators from the best medical institutions into the field of ME/CFS, lowering the barriers to participation in the field of advancing ME/CFS research. Read more in part 2 of 4 in the series…